Effect of Early Recombinant Human Erythropoietin on Neurodevelopmental Outcomes at Age 5 Years-Reply
- PMID: 33847718
- DOI: 10.1001/jama.2021.0836
Effect of Early Recombinant Human Erythropoietin on Neurodevelopmental Outcomes at Age 5 Years-Reply
Comment on
-
Effect of Early Recombinant Human Erythropoietin on Neurodevelopmental Outcomes at Age 5 Years.JAMA. 2021 Apr 13;325(14):1470-1471. doi: 10.1001/jama.2021.0833. JAMA. 2021. PMID: 33847720 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources